Navigation Links
Waismann Method Survey Reveals Dependency Risk for People Using,Suboxone

ect their efforts towards helping patients understand that relapse is not part of recovery. In addition, the antiquated notion that addiction is an incurable disease and belief that 'once an addict, always an addict,' needs to be dispelled. Patients are tired of being hostages of a belief that they must be eternally dependent on treatments and maintenance drugs. We must stop applying judgment, and start offering an effective solution that will keep them from returning to the treatment centers time after time."

To speak with Clare Waismann or a former Suboxone user, please contact Katie Williams at 619-234-0345 or Williams@formulapr.com.

For more information about the Waismann Method, visit www.opiates.com. To schedule an interview please contact Katie Williams at 619-234-0345 or Williams@formulapr.com.

About the Waismann Method

Drs. Clifford A. Bernstein is the medical director of Anesthesia Assisted Medical Opiate Detoxification Inc. (A.A.M.O.D.). A.A.M.O.D. uses the exclusive Waismann Method of Neuro-Regulation to treat opiate dependency. Performed in a hospital intensive care unit, the Waismann Method involves cleansing opiate receptors in a patient's brain of the narcotics while the patient is under anesthesia, reversing the chemical imbalance. During the procedure, the patient will experience minimal conscious withdrawal, and will be able to return home within days. Over 65 percent of the patients who are treated with the Waismann Method remain drug free after one year. The Waismann Foundation, founded by Clare Waismann, is headquartered in Beverly Hills, Calif.

Contact

Formula
Katie Williams, 619-234-0345
Williams@formulapr.com


'"/>




Page: 1 2

Related medicine technology :

1. Waismann Method Survey Reveals 65 Percent of Women Seeking Opiate Dependency Treatment Are Mothers
2. New Point-of-Care Methods to Measure Coronary and Cerebrovascular Risk
3. Researchers Discover Method for Identifying How Cancer Evades the Immune System
4. Second Successful Quigley QR-443 Study Suggests Method of Action Relevant to Broad Range of Chronic Inflammatory Diseases - Human Study to Follow -
5. In New Study, Duloxetine Was Equally Effective, Regardless of Switch Method, in Reducing Painful Symptoms in Ssri Non- or Partial-responders with Depression
6. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
7. Women Well-Informed About Breast Cancer, Yet Lacking Knowledge About Current Treatments, New Survey Finds
8. Hypertension Education Foundation Survey Results Announced At American Society For Hypertension Annual Meeting Suggests Improved Control Of High Blood Pressure, But Misconceptions Still Exist
9. Survey: Migraine Patients Taking Potentially Addictive Barbiturate or Opioid Medications Not Approved by FDA as Migraine Treatments
10. New Survey Finds Troubling Data on American Asthma Sufferers
11. Survey Reveals Significant Public Lack of Diabetes Awareness
Post Your Comments:
(Date:8/21/2008)... Aug. 21 /-,Bayer HealthCar...Inc.,(Nasdaq: ONXX ) today announced the companie...enib as Adjuvant Treatment in the Prevention of,Re...ndomized, double-blind,placebo-controlled Phase 3...s as adjuvant treatment, which is treatment follow...
(Date:8/20/2008)...nobia Pharma, an emerging biotech,company focused ...disorders, today announced that the first patient ...een dosed. Enobia is investigating Enzyme,Replacem...of this rare and,often crippling genetic bone diso...nder two separate protocols, ENB-0040 will be eval...
(Date:8/19/2008)...-,Pharmaceutical company Ph...hat the Phase 3 clinical trial evaluating the long...iectasis has concluded with no serious,adverse eve...treatment., A total of 123 subjects started treat...ubjects completed the full 12 months of the trial....
(Date:8/19/2008)...be used to identify molecular,signature of motor n...ire-USNewswire/ -- ALS Therapy,Development Institu...n ALS,biomarker effort using blood samples collect...ships. These ongoing projects are part of the,Inst...expression of genes,and proteins, at the onset of,...
Breaking Medicine Technology:Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer 2Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer 3Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer 4Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer 5Enobia Pharma Initiates Clinical Testing of Enzyme Replacement Therapy to Treat Hypophosphatasia 2Enobia Pharma Initiates Clinical Testing of Enzyme Replacement Therapy to Treat Hypophosphatasia 312 Month Phase 3 Trial Finds Bronchitol Safe in Bronchiectasis 212 Month Phase 3 Trial Finds Bronchitol Safe in Bronchiectasis 3ALS Therapy Development Institute Partners with Clinical Centers to Establish Pathological Mechanisms of Lou Gehrig's Disease 2ALS Therapy Development Institute Partners with Clinical Centers to Establish Pathological Mechanisms of Lou Gehrig's Disease 3Researchers discover natural herbicide released by grass 1144 1Researchers discover natural herbicide released by grass 1144 2St Jude program reduces weight gain in young African American girls 5856 1St Jude program reduces weight gain in young African American girls 5856 2Skin Cancer Prevention Update 3A 5853 1Skin Cancer Prevention Update 3A 5853 2Skin Cancer Prevention Update 3A 5853 3Skin Cancer Prevention Update 3A 5853 4Skin Cancer Prevention Update 3A 5853 5Feeling Stressed 3F 5850 1Feeling Stressed 3F 5850 2Feeling Stressed 3F 5850 3Feeling Stressed 3F 5850 4
...ased Enzyme Levels in Two Most Common Mutations, C...us,Therapeutics, a biopharmaceutical company devel...logical chaperones for the,treatment of a range of...ill present the results of preclinical studies of,...cher disease at,the of Medical Genetics (ACMG) ann...
...clinical Studies Presented at the Targeted,Antican... Molecular,Targets for Cancer Meetings Support Pha...rch 20, 2007,/PRNewswire-FirstCall/ -- Sunesis Pha...n its development-stage compound, SNS-314, at,two ...ticancer,medicines. Findings from in vitro and in ...
Other Medicine Technology:Amicus Therapeutics Presents Preclinical Data from Studies of,Plicera for Gaucher Disease 2Amicus Therapeutics Presents Preclinical Data from Studies of,Plicera for Gaucher Disease 3Sunesis Pharmaceuticals Presents SNS-314 Aurora Kinase Inhibitor,Data Showing Broad Anti-Tumor Activity, Dosing Flexibility 2Sunesis Pharmaceuticals Presents SNS-314 Aurora Kinase Inhibitor,Data Showing Broad Anti-Tumor Activity, Dosing Flexibility 3
(Date:8/21/2008)... New names and fresh websit... UME/GME administration software , ... one45 Software, a leading provider of healthcare ... of Cytiva Software Inc. (CRX:TSX.V), announced to...hcare education administration products., , ,Compl...
(Date:8/20/2008)... NEWTON, Mass., Aug. 20 /PRNewswire/ -- Questex M...o-business media company and owner of,American Spa... and the,International Beauty Shows, the Internati...) and the SPATEC appointment events today announce...stry portals SpaTrade (, http://www.SpaTrade.com ...
(Date:8/20/2008)... Survey Report Is Available at http://ww...Newswire/ -- A new survey released today,documents...re leveraging,health information technology (HIT) ...The survey results highlight the need for many HIT...dization and,interoperability to optimize clinical...
(Date:8/20/2008)...use postponed reproductive onset in teen, adult fe...EDNESDAY, Aug. 20 (HealthDay News) -- Alcoholism i...ccording to a study that compared women,s and men,... age when they had their first child. , The re...ian twins born between 1893-1964 (3,634 female and...
Breaking Medicine News(10 mins):Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 2Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 3Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 4Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 2Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 3Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 2Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 3Health News:Women's Alcohol Use Tied to Delayed Childbearing 2
...ing system for use by physicians predicts early ri...ransient ischemic attack, known as TIA and also ca...out 240,000 TIAs are diagnosed every year in the U...United Kingdom. A TIA is a serious condition cause...
...nase (ADH) is one of the major enzymes involved in...phic at two loci, ADH1B and ADH1C.// The three al...ed with protection from alcohol dependence, a new ...tionship between the ADH1B*3 allele and alcohol-re...
...global acquisitions last year, India's Ranbaxy Lab...the generic drugs business of German// pharmaceuti...llion. ‘We are in talks with private equity funds... executive Malvinder Singh said on the margins of ...
...ochrane Review concluded antidepressants bupropion...es //of giving up smoking and have few side-effect...RIs) such as fluoxetine (Prozac) are not effective...own to help people quit smoking, not everyone is h...
Other Medicine News:Health News:New Tool Improves Prediction of Stroke Risk 2Health News:Alcohol Dehydrogenase Gene may Protect from Developing Alcoholism 2Health News:Alcohol Dehydrogenase Gene may Protect from Developing Alcoholism 3
The QIAamp Viral RNA Mini Kit allows purification of viral nucleic acids from cell-free fluid samples. Examples of viral nucleic acids that can be isolated with this kit include, but are not limited
The PersonalLAB junior is an automated microplate analyzer capable of fully automating immunoenzymatic techniques using a microplate format, per the reagent manufacturer's instruction for use and spe
MAP D-Type can combine a number of assay steps for up to 180 microplates on a simple to use benchtop device. The D-Type base instrument is a multifunctional stand-alone device but also provides easy
Grab one and go, One of the smallest handheld oximeters available, Datex-Ohmeda s TuffSat is the ideal spot-check solution for hospital, home care, transport, and EMS. TuffSat comes fully loaded wi
Medicine Products: